Vijaya Diagnostic Centre Limited
Bookbuilding IPO · NSE, BSE
- Price band
- ₹522 - ₹531
- Lot size
- 28 shares
- Issue amount
- ₹1,894 cr
- Total subscription
- 0×
- Opens
- 1 Sept 2021
- Closes
- 3 Sept 2021
- Allotment
- 8 Sept 2021
- Listing
- 14 Sept 2021
Offer at a glance
Issue overview
- Issue size
- 3,56,88,064 shares
- Face value
- ₹1 Per Share
- Minimum investment
- ₹14,616
- Fresh issue
- ₹0 cr
- Offer for sale
- ₹1,895.04 cr
- Registrar
- Kfin Technologies Limited
- Listing exchange
- NSE, BSE
- Maximum investment
- ₹14,868
- Issue type
- Bookbuilding IPO
- Shares before issue
- 10,19,65,926
- Shares after issue
- 10,19,65,926
Lot sizes
| Category | Lots | Shares | Amount |
|---|---|---|---|
| RETAIL | 1 | 28 | ₹14,868 |
| sHNI | 14 | 392 | ₹2,08,152 |
| bHNI | 68 | 1,904 | ₹10,11,024 |
Share reservation
Subscription & GMP
Subscription by category
Subscription figures are awaiting publication.
GMP history
Financial performance
Company financials
In Lakhs · Reported periods may include interim results.
Company information
Company profile
Established in 1981, Vijaya Diagnostic Centre is a leading diagnostic chain in Southern India, offering comprehensive pathology and radiology services with around 740 routine tests, 870 specialized pathology tests, 220 basic radiology tests, and 320 advanced radiology tests, along with customized health and wellness packages. The company operates 80 diagnostic centers and 11 reference laboratories across 13 cities in Telangana, Andhra Pradesh, the National Capital Region, and Kolkata, with 96.2% of revenue coming from Hyderabad and nearby regions. In the year ended March 31, 2021, Vijaya Diagnostic Centre conducted approximately 6.20 million pathology tests and 0.89 million radiology tests for about 2.63 million customers, and all its laboratories hold NABL accreditation, with three centers also holding NABH accreditation.
Strengths
- Leading Diagnostic Chain: Largest and fastest-growing in Southern India.
- Affordable & Comprehensive Services: One-stop diagnostics with superior quality focus.
- Advanced Technology: Strong technical capabilities with cutting-edge testing and robust IT infrastructure.
- Accredited Laboratories: All labs hold National Accreditation.
- High Brand Recall: Drives strong individual consumer business.
Promoters
Dr. S. Surendranath Reddy
Registrar & documents
Lead manager
Edelweiss Financial Services Limited, ICICI Securities Limited, Kotak Mahindra Capital Company Limited
Registrar & contacts
Kfin Technologies Limited
[email protected]Official registrar portal ↗IPO allotment status guide →Registered office
3-6-16 & 17, Street No. 19, Himayatnagar Hyderabad, 500 029
+91 40 2342 0411
[email protected]Company website ↗Understanding VIJAYA IPO data
Compare the price band and required investment with the company profile, financial results and offer documents. Subscription figures show reported demand by category; they do not establish the value of the business. GMP is an unofficial indication and can change before listing.